Island eyes FDA fast track Animal Rule
Island Pharmaceuticals hopes the FDA will approve its acquired asset Galidesivir on the back of animal testing alone.
Island Pharmaceuticals hopes the FDA will approve its acquired asset Galidesivir on the back of animal testing alone.
Re-testing of D3E’s RBD10 well in South Africa has delivered an average gas flow rate of 276 Mscfd, a 39% increase on previous testing.
The ASX found some momentum in the energy sector today, rising 0.08pc despite general anxieties over US tariff impacts.
Resolution Minerals has enlisted two Trump-affiliated firms to back its Horse Heaven antimony-tungsten project in proposed Nasdaq listing
Recent fixed-loop EM surveys at the Oval copper-nickel project in Mongolia have mapped multiple conductive plates matching key structural targets.
Argentina’s investment-friendly policies and underexplored lands have proven irresistible for mining companies.
Coal could have a far longer shelf-life then renewable advocates hope, as energy security and the AI race shake up the energy transition.
Orthocell has made a strong addition to its board as it accelerates plans for US commercialisation, appointing highly experienced director Michael McNulty.
Albion Resources’ drilling is off to a flying start with all 12 first holes at the Collavilla prospect returning gold intersections.
Codeifai says due diligence on acquisition of AI backed quantum-secure platform AntennaTransfer.io is progressing well and expected to close in September.
Pancontinental Energy is currently exploring in the same waters as a number of majors off the coast of Namibia.
Some dull trading overnight in New York has still seen more record highs for the S&P500 and the Nasdaq Composite ahead of key inflation data.
Original URL: https://www.couriermail.com.au/business/stockhead/page/13